Telesis Bio Profit Margin

Telesis Bio (TBIO) currently reports a profit margin of -336.59% as of September 2024. That compares with -127.23% in the prior-year period — down 164.6% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Telesis Bio's profit margin history and peer comparisons.

Telesis Bio's profit margin decreased from -127.23% to -336.59% — a 164.6% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telesis Bio's profit margin of -336.59% is lower than the Healthcare sector average of 15.29%. That is roughly 2301.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Telesis Bio's current -336.59% should be judged against Healthcare norms (sector average: 15.29%) and against TBIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -336.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Telesis Bio, and consider following TBIO for alerts when major investors trade the stock.